Capitalizing on Personalized Care in IDH-Mutant Gliomas: Expert Guidance on The Use of Biomarker Testing & Targeted Therapies in Real-World Settings

Capitalizing on Personalized Care in IDH-Mutant Gliomas: Expert Guidance on The Use of Biomarker Testing & Targeted Therapies in Real-World Settings

Capitalizing on Personalized Care in IDH-Mutant Gliomas: Expert Guidance on The Use of Biomarker Testing & Targeted Therapies in Real-World Settings

  • Provider:PVI, PeerView Institute for Medical Education
  • Activity Link: https://www.peerview.com/HZS
  • Start Date: 2024-11-22 06:00:00
  • End Date: 2024-11-22 06:00:00
  • Credit Details: AAPA Category 1 Credit™️: 1.0 hours
    AMA PRA Category 1 Credit™️: 1.0 hours
  • MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
    ABIM - 1.0 Point; Credit Type(s): Patient Safety (ABIM)
  • Commercial Support: Source: Servier Pharmaceuticals - Amount: 69695.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Jointly Provided
  • Registration: Open to all
  • Specialty: Medical Oncology
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.